InVivo Therapeutics Holdings Corporation NVIV
0.32 +0.32
Day range unavailable
52-week range unavailable
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -10.65M | -9.90M | -9.10M | -11.50M | -12.77M | |
| -10.49M | -9.89M | -9.07M | -11.83M | -23.42M | |
| -6.83 | -7.48 | -32.75 | -882.00 | -3,520.25 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 16.35M | 19.03M | 19.49M | 6.61M | 16.66M | |
| 18.82M | 21.77M | 21.91M | 9.32M | 18.38M | |
| 3.08M | 3.65M | 2.72M | 3.74M | 2.27M | |
| 949.00K | 1.31M | 1.02M | 1.31M | 100.00K | |
| 15.75M | 18.11M | 19.19M | 5.58M | 16.11M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -10.48M | -8.85M | -9.53M | -10.31M | -12.31M | |
| -160.00K | -77.00K | -41.00K | -12.00K | -65.00K | |
| 7.96M | 8.51M | 22.46M | 268.00K | 15.88M | |
| -160.00K | -77.00K | -41.00K | -12.00K | -65.00K | |
| -2.68M | -422.00K | 12.89M | -10.06M | 3.50M |